Velan Capital Investment Management LP - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 224 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
Velan Capital Investment Management LP ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,137,500
-32.7%
250,000
+4.2%
0.92%
-41.6%
Q2 2023$1,689,600
+25.7%
240,000
+9.1%
1.57%
+36.9%
Q1 2023$1,344,200220,0001.15%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,876,600$127,618,00011.48%
Fairmount Funds Management LLC 596,890$19,650,0008.32%
Ghost Tree Capital, LLC 575,000$18,929,0005.47%
Perceptive Advisors 10,085,632$332,019,0004.85%
Avoro Capital Advisors LLC 9,536,039$313,926,0004.46%
FRAZIER MANAGEMENT LLC 1,312,999$43,224,0003.88%
ACUTA CAPITAL PARTNERS, LLC 315,000$10,370,0002.82%
Orbimed Advisors 6,645,100$218,757,0002.75%
QVT Financial LP 572,971$18,862,0002.30%
Prosight Management, LP 120,606$3,970,0001.89%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders